Surgalign's FDA clearance and three more updates from spine device companies since Aug. 24.
1. Surgalign's Cortera spinal fixation system received FDA 510(k) clearance.
2. Xtant Medical entered an agreement to sell common stock and warrants to investors. The investment is expected to be about $9.75 million.
3. Aurora Spine saw record sales in the second quarter of 2022. Second-quarter sales of $4.1 million represented a 67.7 percent increase year over year.
4. Augmedics' Xvision spine system was used in its 2,000th case. John Stevenson, MD, performed the company's milestone case in Gainesville, Fla.